Expression of ERa,ERß and co-regulator PELP1/MNAR in colorectal cancer: Prognostic significance and clinicopathologic correlations

Cellular Oncology

Volumn 31, Issue 3, 2009, Pages 235-247

  Grivas, Petros D ^a,b,d   Tzelepi, Vassiliki ^a   Sotiropoulou Bonikou, Georgia ^a   Kefalopoulou, Zinovia ^a   Papavassiliou, Athanasios G ^c   Kalofonos, Haralabos ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b HAHNEMANN UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Colorectal cancer; Estrogen receptora ; Immunohistochemistry; PELP1 MNAR; Tumorigenesis

Indexed keywords

ADAPTOR PROTEIN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTOR BETA 1; GLUTAMIC ACID; LEUCINE; MODULATOR OF NON GENOMIC ACTIVITY OF ESTROGEN RECEPTOR; PROLINE; PROLINE GLUTAMIC ACID AND LEUCINE RICH PROTEIN 1; REGULATOR PROTEIN; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG; PELP1 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ADULT; AGED; ARTICLE; CARCINOGENESIS; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; EPITHELIUM CELL; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MYOFIBROBLAST; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SEX DIFFERENCE; CARCINOMA; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; INTESTINE MUCOSA; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; COLORECTAL NEOPLASMS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PROGNOSIS; TRANS-ACTIVATORS;

EID: 67650241992     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: 10.3233/CLO-2009-0467     Document Type: Article

References (50)

1. G. Fiorelli, L. Picariello, V. Martineti, F. Tonelli and M.L. Brandi, Functional estrogen receptor beta in colon cancer cells, Biochem. Biophys. Res. Commun. 261(1999), 521-527.
2. P.A. Konstantinopoulos, A. Kominea, G. Vandoros, G.P. Sykio- tis, P. Andricopoulos, I. Varakis, G. Sotiropoulou-Bonikou and A.G. Papavassiliou, Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentia- tion, Eur. J. Cancer 39(2003), 1251-1258.
3. J.T. Moore, D.D. McKee, K. Slentz-Kesler, L.B. Moore, S.A. Jones, E.L. Horne, J.L. Su, S.A. Kliewer, J.M. Lehmann and T.M. Willson, Cloning and characterization of human estrogen receptor beta isoforms, Biochem. Biophys. Res. Commun. 247(1998), 75-78.
4. A. Cavallini, C. Messa, M. Pricci, M.L. Caruso, M. Barone and A. Di Leo, Distribution of estrogen receptor subtypes, expression of their variant forms, and clinicopathological characteristics of human colorectal cancer, Dig. Dis. Sci. 47(2002), 2720-2728.
5. S. Nilsson, S. Makela, E. Treuter, M. Tujague, J. Thomsen, G. Andersson, E. Enmark, K. Pettersson, M. Warner and J.A. Gustafsson, Mechanisms of estrogen action, Physiol. Rev. 81(2001), 1535-1565.
6. E.V. Jensen and V.C. Jordan, The estrogen receptor: a model for molecular medicine, Clin. Cancer Res. 9(2003), 1980-1989.
7. B. Peng, B. Lu, E. Leygue and L.C. Murphy, Putative functional characteristics of human estrogen receptor-beta iso- forms, J. Mol. Endocrinol. 30(2003), 13-29.
8. F. Acconcia and R. Kumar, Signaling regulation of genomic and nongenomic functions of estrogen receptors, Cancer Lett. 238(2006), 1-14.
9. R.K. Vadlamudi, R.A. Wang, A. Mazumdar, Y. Kim, J. Shin, A. Sahin and R. Kumar, Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha, J. Biol. Chem. 276(2001), 38272-38279.
10. R.K. Vadlamudi and R. Kumar, Functional and biological properties of the nuclear receptor coregulator PELP1/MNAR, Nucl. Recept. Signal. 5(2007), e004.
11. S.K. Mishra, S. Balasenthil, D. Nguyen and R.K. Vadlamudi, Cloning and functional characterization of PELP1/MNAR promoter, Gene 330(2004), 115-122.
12. S.S. Nair, S.K. Mishra, Z. Yang, S. Balasenthil, R. Kumar and R.K. Vadlamudi, Potential role of a novel transcriptional coac- tivator PELP1 in histone H1 displacement in cancer cells, Cancer Res. 64(2004), 6416-6423.
13. Y.B. Choi, J.K. Ko and J. Shin, The transcriptional corepressor, PELP1, recruits HDAC2 and masks histones using two separate domains, J. Biol. Chem. 279(2004), 50930-50941.
14. C.W. Wong, C. McNally, E. Nickbarg, B.S. Komm and B.J. Cheskis, Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade, Proc. Natl. Acad. Sci. USA 99(2002), 14783-14788.
15. S. Nair and R.K. Vadlamudi, Emerging significance of ER- coregulator PELP1/MNAR in cancer, Histol. Histopathol. 22(2007), 91-96.
16. B. Manavathi, S.S. Nair, R.A. Wang, R. Kumar and R.K. Vad- lamudi, Proline-, glutamic acid-, and leucine-rich protein-1 is essential in growth factor regulation of signal transducers and activators of transcription 3 activation, Cancer Res. 65(2005), 5571-5577.
17. S. Balasenthil and R.K. Vadlamudi, Functional interactions between the estrogen receptor coactivator PELP1/MNAR and retinoblastoma protein, J. Biol. Chem. 278(2003), 22119-22127.
18. E. Unni, S. Sun, B. Nan, M.J. McPhaul, B. Cheskis, M.A. Mancini and M. Marcelli, Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence, Cancer Res. 64(2004), 7156-7168.
19. R.K. Vadlamudi, S. Balasenthil, R.R. Broaddus, J.A. Gustafs- son and R. Kumar, Deregulation of estrogen receptor coac- tivator proline-, glutamic acid-, and leucine-rich protein-1/ modulator of nongenomic activity of estrogen receptor in human endometrial tumors, J. Clin. Endocrinol. Metab. 89(2004), 6130-6138.
20. P. Grivas, A. Antonacopoulou, V. Tzelepi, G. Sotiropoulou- Bonikou, Z. Kefalopoulou, A.G. Papavassiliou and H. Kalo- fonos, HER-3 in colorectal tumourigenesis: from mRNA levels through protein status to clinicopathologic relationships, Eur. J. Cancer 43(2007), 2602-2611.
21. N. Jassam, S.M. Bell, V. Speirs and P. Quirke, Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes' staging, Oncol. Rep. 14(2005), 17-21.
22. D. Witte, M. Chirala, A. Younes, Y. Li and M. Younes, Estrogen receptor beta is expressed in human colorectal adenocarci-noma, Hum. Pathol. 32(2001), 940-944.
23. N.A. Wong, R.D. Malcomson, D.I. Jodrell, N.P. Groome, D.J. Harrison and P.T. Saunders, ERbeta isoform expression in col- orectal carcinoma: an in vivoand in vitrostudy of clinicopatho- logical and molecular correlates, J. Pathol. 207(2005), 53-60.
24. R.K. Vadlamudi, S. Balasenthil, A.A. Sahin, M. Kies, R.S. Weber, R. Kumar and A.K. El-Naggar, Novel estrogen receptor coactivator PELP1/MNAR gene and ERbeta expression in salivary duct adenocarcinoma: potential therapeutic targets, Hum. Pathol. 36(2005), 670-675.
25. F.J. Secreto, D.G. Monroe, S. Dutta, J.N. Ingle and T.C. Spels- berg, Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells, J. Cell. Biochem. 101(5) (2007), 1125-1147.
26. L.M. McShane, D.G. Altman, W. Sauerbrei, S.E. Taube,M. Gion and G.M. Clark, REporting recommendations for tumor MARKer prognostic studies (REMARK), Nat. Clin. Pract. Oncol. 2(2005), 416-422.
27. M. Hu and K. Polyak, Microenvironmental regulation of cancer development, Curr. Opin. Genet. Dev. 18(2008), 27-34.
28. P.S. Cooke, D.L. Buchanan, P. Young, T. Setiawan, J. Brody, K.S. Korach, J. Taylor, D.B. Lubahn and G.R. Cunha, Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium, Proc. Natl. Acad. Sci. USA 94(1997), 6535-6540.
29. G.R. Cunha, P. Young, Y.K. Hom, P.S. Cooke, J.A. Taylor and D.B. Lubahn, Elucidation of a role for stromal steroid hormone receptors in mammary gland growth and development using tissue recombinants, J. Mammary. Gland. Biol. Neoplasia 2(1997), 393-402.
30. G.S. Prins, L. Birch, J.F. Couse, I. Choi, B. Katzenellenbo-gen and K.S. Korach, Estrogen imprinting of the developing prostate gland is mediated through stromal estrogen receptor alpha: studies with alphaERKO and betaERKO mice, Cancer Res. 61(2001), 6089-6097.
31. P.B. Gupta, D. Proia, O. Cingoz, J. Weremowicz, S.P. Naber, R.A. Weinberg and C. Kuperwasser, Systemic stromal effects of estrogens promote the growth of estrogen receptor-negative tumors, Cancer Res. 67(2007), 2062-2071.
32. E.F. Foley, A.A. Jazaeri, M.A. Shupnik, O. Jazaeri and L.W. Rice, Selective loss of estrogen receptor beta in malignant human colon, Cancer Res. 60(2000), 245-248.
33. M. Campbell-Thompson, I.J. Lynch and B. Bhardwaj, Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer, Cancer Res. 61(2001), 632-640.
34. J. Matthews and J.A. Gustafsson, Estrogen signaling: a subtle balance between ER alpha and ER beta, Mol. Interv. 3(2003), 281-292.
35. O. Wada-Hiraike, M. Warner and J.A. Gustafsson, New developments in oestrogen signalling in colonic epithelium, Biochem. Soc. Trans. 34(2006), 1114-1116.
36. M.J. Gunter, D.R. Hoover, H. Yu, S. Wassertheil-Smoller, T.E. Rohan, J.E. Manson, B.V. Howard, J. Wylie-Rosett, G.L. Anderson, G.Y. Ho, R.C. Kaplan, J. Li, X. Xue, T.G. Harris, R.D. Burk and H.D. Strickler, Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in post- menopausal women, Cancer Res. 68(2008), 329-337.
37. S. Narayan, G. Rajakumar, H. Prouix and P. Singh, Estradiol is trophic for colon cancer in mice: effect on ornithine decarboxylase and c-myc messenger RNA, Gastroenterology 103(1992), 1823-1832.
38. S. Singh, C. Paraskeva, P.H. Gallimore, M.C. Sheppard and M.J. Langman, Differential growth response to oestrogen of premalignant and malignant colonic cell lines, Anticancer Res. 14(1994), 1037-1041.
39. D.C. Winter, C. Taylor, C.G. O'Sullivan and B.J. Harvey, Mito- genic effects of oestrogen mediated by a non-genomic receptor in human colon, Br. J.Surg. 87(2000), 1684-1689.
40. N. Arai, A. Strom, J.J. Rafter and J.A. Gustafsson, Estrogen receptor beta mRNA in colon cancer cells: growth effects of estrogen and genistein, Biochem. Biophys. Res. Commun. 270(2000), 425-431.
41. M. Di Domenico, G. Castoria, A. Bilancio, A. Migliaccio and F. Auricchio, Estradiol activation of human colon carcinoma- derived Caco-2 cell growth, Cancer Res. 56(1996), 4516-4521.
42. B.A. Hennessy, B.J. Harvey and V. Healy, 17beta-Estradiol rapidly stimulates c-fos expression via the MAPK pathway in T84 cells, Mol. Cell. Endocrinol. 229(2005), 39-47.
43. O.O. Oduwole, V.V. Isomaa, P.A. Nokelainen, F. Stenback and P.T. Vihko, Downregulation of estrogen-metabolizing 17 beta- hydroxysteroid dehydrogenase type 2 expression correlates inversely with Ki67 proliferation marker in colon-cancer development, Int. J. Cancer 97(2002), 1-6.
44. M.A. English, K.F. Kane, N. Cruickshank, M.J. Langman, P.M. Stewart and M. Hewison, Loss of estrogen inactivation in colonic cancer, J. Clin. Endocrinol. Metab. 84(1999), 2080-2085.
45. J.Y. Guo, X. Li, J.D. Browning Jr., G.E. Rottinghaus, D.B. Lubahn, A. Constantinou, M. Bennink and R.S. MacDonald, Dietary soy isoflavones and estrone protect ovariectomized ER- alphaKO and wild-type mice from carcinogen-induced colon cancer, J. Nutr. 134(2004), 179-182.
46. B. Iacopetta, Are there two sides to colorectal cancerfi, Int. J. Cancer 101(2002), 403-408.
47. P.A. O'Neill, M.P. Davies, A.M. Shaaban, H. Innes, A. Torev- ell, D.R. Sibson and C.S. Foster, Wild-type oestrogen receptor beta (ERbeta1) mRNA and protein expression in Tamoxifen- treated post-menopausal breast cancers, Br. J. Cancer 91(2004), 1694-1702.
48. J.G. Greger, Y. Guo, R. Henderson, J.F. Ross and B.J. Cheskis, Characterization of MNAR expression, Steroids 71(2006), 317-322.
49. R. Rajhans and R.K. Vadlamudi, Comprehensive analysis of recent biochemical and biologic findings regarding a newly discovered protein-PELP1/MNAR, Clin. Exp. Metastasis 23(2006), 1-7.
50. S.K. Rayala, J. Mascarenhas, R.K. Vadlamudi and R. Kumar, Altered localization of a coactivator sensitizes breast cancer cells to tumor necrosis factor-induced apoptosis, Mol. Cancer Ther. 5(2006), 230-237.